FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Vaccine Experts Fear Trump Pressure on Covid Tests: CNN

CNN says vaccine experts it interviewed are concerned that the White House will pressure FDA to approve a coronavirus vaccine before it has been adequ...

Human Drugs

5 Companies Recall Some Metformin ER Drugs

FDA identifies five companies that have recalled certain metformin extended-release products following agency testing showing levels of N-Nitrosodimet...

FDA General

Congressional Committees Set Appropriations Mark-Ups

The Alliance for a Stronger FDA says congressional appropriations committees will be marking up bills for the FY 21 appropriations later this month an...

FDA Workload Likely to Increase Post-Pandemic: Officials

CDER and CBER officials tell a BIO digital conference that they are working to cope with pent-up demand and clinical trial issues in a post-Covid worl...

Human Drugs

FDA Approves Tivicay for Infants, Children with HIV

FDA approves Viivs Tivicay and Tivicay PD for treating pediatric patients for HIV-1.

Federal Register

Comments Extended on Animal Bulk Compounding

Federal Register notice: FDA extends until 10/15 the comment period related to a draft guidance for industry #256 entitled Compounding Animal Drugs fr...

Human Drugs

FDA Approves Mylans Semglee Insulin Glargine

FDA approves Mylans Semglee insulin glargine product as a BLA.

Human Drugs

IntelGenx Working on Rizaport NDA Resubmission

IntelGenx says it learned in a 6/10 meeting with FDA officials about the CMC information that is needed in a resubmission of its Rizaport VersaFilm ND...

Human Drugs

Lannett Sees Clear Path for Insulin Glargine Biosimilar

Lannett says it is on track for a 2022 submission of a BLA for its insulin glargine biosimilar product.

Medical Devices

Covid-19 Diagnostic Test Virtual Town Hall Set

FDA schedules a 6/17 SARS-CoV-2 diagnostic test development and validation virtual town hall.